Engineered human pluripotent stem cell-derived natural killer cells: the next frontier for cancer immunotherapy

Adoptive immunotherapy using immune effector cells has revolutionized cancer treatments with approval of two autologous chimeric antigen receptor (CAR) T cell therapies by the US FDA. Clinical trials using natural killer (NK) cell-based adoptive immunotherapy have been shown to be safe and effective...

Full description

Bibliographic Details

Published in:	Blood science Vol. 1; no. 1; pp. 4 - 11
Main Authors:	Zhu, Huang, Kaufman, Dan S.
Format:	Journal Article
Language:	English
Published:	United States The Authors. Published by Wolters Kluwer Health Inc., on behalf of the Chinese Association for Blood Sciences 01-08-2019 Wolters Kluwer Health
Subjects:	Review Adoptive NK cell therapy Natural killer cells Chimeric antigen receptor Human stem cells Cancer immunotherapy CAR-NK cells
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!